About Dharma Pharmaceuticals
Dharma Pharmaceuticals was established in 2018 and is based in Bristol, United States. Operations are conducted in the pharmaceuticals sector, with a focus on producing cannabis-derived products for medical applications. Manufacturing processes are centered on these items, which are developed to meet regulatory standards. The company is led by co-founders holding positions as CEO, COO, and CPO, overseeing product development and distribution.
- Headquarter Bristol, United States
- Founders Jack L Page, Shanna Berry, Michael Johnson
-
Sectors
Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dharma Pharmaceuticals
Detailed funding history for Dharma Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Dharma Pharmaceuticals
Dharma Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include GTI Grows.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis-related health and wellbeing products are provided nationally.
|
Locked | Locked | Locked |
Investor details for Dharma Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dharma Pharmaceuticals
Investment portfolio details for Dharma Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dharma Pharmaceuticals
Detailed financials for Dharma Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dharma Pharmaceuticals Comparisons
Peer comparison for Dharma Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dharma Pharmaceuticals
Detailed competitors of Dharma Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dharma Pharmaceuticals
Complete news archive for Dharma Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dharma Pharmaceuticals
Dharma Pharmaceuticals was founded in 2018.
Dharma Pharmaceuticals is headquartered in Bristol, United States.
Shanna Berry is the current CEO of Dharma Pharmaceuticals. They have also founded this company.
Dharma Pharmaceuticals was established in 2018 and is based in Bristol, United States. Operations are conducted in the pharmaceuticals sector, with a focus on producing cannabis-derived products for medical applications. Manufacturing processes are centered on these items, which are developed to meet regulatory standards. The company is led by co-founders holding positions as CEO, COO, and CPO, overseeing product development and distribution.
Dharma Pharmaceuticals has 1 investor. Key investors include GTI Grows.